Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 33 (5) , 475-482
- https://doi.org/10.1016/0024-3205(83)90797-x
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The regional distribution of somatostatin, substance P and neurotensin in human brainBrain Research, 1981
- Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer typeLife Sciences, 1981
- Retention deficits after combined amygdalo-hippocampal and selective hippocampal resections in the monkeyNeuropsychologia, 1981
- Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementaNature, 1980
- INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIAThe Lancet, 1978
- Is somatostatin an excitatory transmitter in the hippocampus?Nature, 1978
- Calcium-dependent release of somatostatin and neurotensin from rat brain in vitroNature, 1978
- Current problems in the measurement of gastrin release. A reproducible measure of physiological gastrin releasePublished by Oxford University Press (OUP) ,1976
- SCHIZOPHRENIA AND THE LIMBIC SYSTEMThe Lancet, 1974
- The Schizophrenia-like Psychoses of EpilepsyThe British Journal of Psychiatry, 1963